MGMT and glioblastoma: Glioblastoma is a heterogeneous tumor entity with various prognostic and predictive factors, including clinical (patient age, Karnofsky performance status) and molecular characteristics (O6-methylguanine DNA methyltransferase promoter methylation status, MGMT status) (7, 8) affecting survival and treatment response.